ALS (AMYOTROPHIC LATERAL SCLEROSIS)
Clinical trials for ALS (AMYOTROPHIC LATERAL SCLEROSIS) explained in plain language.
Never miss a new study
Get alerted when new ALS (AMYOTROPHIC LATERAL SCLEROSIS) trials appear
Sign up with your email to follow new studies for ALS (AMYOTROPHIC LATERAL SCLEROSIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cord blood transplant trial offers new hope for ALS patients
Disease control ENROLLING_BY_INVITATIONThis study tests whether a transplant of umbilical cord blood can slow the progression of ALS, a fast-moving nerve disease. The idea is that the transplant may calm harmful inflammation in the brain and spinal cord. Eight adults with early-stage ALS will receive the transplant an…
Matched conditions: ALS (AMYOTROPHIC LATERAL SCLEROSIS)
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 17, 2026 03:38 UTC
-
Heart drug digoxin tested to slow ALS progression
Disease control OngoingThis phase 2a trial tests whether the heart medication digoxin is safe and can slow nerve damage in people with ALS. About 40 adults with early-stage ALS will take oral digoxin for 24 weeks. Researchers will monitor side effects and measure blood markers of nerve health to see if…
Matched conditions: ALS (AMYOTROPHIC LATERAL SCLEROSIS)
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Robot helper lets people with disabilities feed themselves
Symptom relief OngoingThis study tests a robotic feeding device called Obi Gen 3 for people who have trouble using their arms or hands due to conditions like cerebral palsy, ALS, or Rett syndrome. About 50 participants, including patients, caregivers, and healthcare providers, will use the device at h…
Matched conditions: ALS (AMYOTROPHIC LATERAL SCLEROSIS)
Sponsor: Desin LLC • Aim: Symptom relief
Last updated May 17, 2026 03:45 UTC
-
Robot suit may help ALS patients keep walking
Symptom relief TerminatedThis study tests whether a robotic exoskeleton called Atalante can safely help people with ALS maintain their ability to walk. Researchers believe that training with the exoskeleton may retrain the brain's walking circuits. The study plans to enroll 20 adults with slow-to-moderat…
Matched conditions: ALS (AMYOTROPHIC LATERAL SCLEROSIS)
Phase: NA • Sponsor: Institut de Recherche sur la Moelle épinière et l'Encéphale • Aim: Symptom relief
Last updated May 17, 2026 03:42 UTC